NO974651D0 - Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose - Google Patents

Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose

Info

Publication number
NO974651D0
NO974651D0 NO974651A NO974651A NO974651D0 NO 974651 D0 NO974651 D0 NO 974651D0 NO 974651 A NO974651 A NO 974651A NO 974651 A NO974651 A NO 974651A NO 974651 D0 NO974651 D0 NO 974651D0
Authority
NO
Norway
Prior art keywords
treatment
biologically active
multiple sclerosis
derivatives useful
ureido derivatives
Prior art date
Application number
NO974651A
Other languages
English (en)
Other versions
NO974651L (no
Inventor
Rachele Alzani
Elena Cozzi
Nicola Mongelli
Andrea Lombardi Borgia
Massimo Temponi
Francesco Colotta
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO974651D0 publication Critical patent/NO974651D0/no
Publication of NO974651L publication Critical patent/NO974651L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO974651A 1996-02-09 1997-10-08 Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose NO974651L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9602721.4A GB9602721D0 (en) 1996-02-09 1996-02-09 Biologically active ureido derivatives useful in the treatment of multiple sclerosis
PCT/EP1997/000412 WO1997028796A1 (en) 1996-02-09 1997-01-24 Biologically active ureido derivatives useful in the treatment of multiple sclerosis

Publications (2)

Publication Number Publication Date
NO974651D0 true NO974651D0 (no) 1997-10-08
NO974651L NO974651L (no) 1997-12-02

Family

ID=10788461

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974651A NO974651L (no) 1996-02-09 1997-10-08 Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose

Country Status (22)

Country Link
US (1) US5859046A (no)
EP (1) EP0820284B1 (no)
JP (1) JPH11504041A (no)
KR (1) KR19980703718A (no)
AR (1) AR005724A1 (no)
AT (1) ATE189388T1 (no)
AU (1) AU1720097A (no)
BR (1) BR9702075A (no)
CA (1) CA2217008A1 (no)
DE (1) DE69701243T2 (no)
DK (1) DK0820284T3 (no)
EA (1) EA000166B1 (no)
ES (1) ES2144844T3 (no)
GB (1) GB9602721D0 (no)
GR (1) GR3033332T3 (no)
HU (1) HUP9900796A2 (no)
IL (1) IL121808A0 (no)
NO (1) NO974651L (no)
PL (1) PL322717A1 (no)
PT (1) PT820284E (no)
WO (1) WO1997028796A1 (no)
ZA (1) ZA97902B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562859B1 (en) 1997-12-04 2003-05-13 The United States Of America As Represented By The Department Of Health And Human Services Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
US6348464B1 (en) 1999-11-12 2002-02-19 Guilford Pharmaceuticals, Inc. Pyrrolecarbonylimino derivatives as naaladase inhibitors
JP4773951B2 (ja) 2003-03-03 2011-09-14 エーザイ インコーポレーテッド チオラクトン
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease

Also Published As

Publication number Publication date
AR005724A1 (es) 1999-07-14
CA2217008A1 (en) 1997-08-14
GR3033332T3 (en) 2000-09-29
DK0820284T3 (da) 2000-07-24
EA199700302A1 (ru) 1998-04-30
US5859046A (en) 1999-01-12
MX9707673A (es) 1997-11-29
BR9702075A (pt) 1998-06-09
DE69701243T2 (de) 2000-09-07
KR19980703718A (ko) 1998-12-05
EP0820284A1 (en) 1998-01-28
ES2144844T3 (es) 2000-06-16
IL121808A0 (en) 1998-02-22
GB9602721D0 (en) 1996-04-10
HUP9900796A2 (hu) 1999-07-28
PT820284E (pt) 2000-07-31
PL322717A1 (en) 1998-02-16
ATE189388T1 (de) 2000-02-15
JPH11504041A (ja) 1999-04-06
EP0820284B1 (en) 2000-02-02
NO974651L (no) 1997-12-02
ZA97902B (en) 1997-08-01
DE69701243D1 (de) 2000-03-09
AU1720097A (en) 1997-08-28
EA000166B1 (ru) 1998-10-29
WO1997028796A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
DE69607321D1 (de) Reinigungsverfahren und zusammensetzung
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
DE69528512D1 (de) Aktiver akustischer Überzug
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
DK0918505T3 (da) Hudtoningsformulering
NO981008L (no) Farmas÷ytisk formulering
DE69302863D1 (de) Wässrige Beschichtungszusammensetzung und diese verwendendes Beschichtungsverfahren
DE69620642D1 (de) Reiningungsverfahren und-zusammensetzung
IL118289A0 (en) The use of glyceryl triacetate for treatment of onychomycoses
FI945164A0 (fi) Biologisesti aktiivisesti ureidojohdannaiset, jotka ovat käyttökelpoisia antimetastaattisina aineina
ATE228575T1 (de) Wirkstoffkombinationen
NO974651D0 (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
NO944809D0 (no) Biologisk aktive ureidoderivater som er nyttig i behandling av lentivirus-indusert sykdom
NO982562D0 (no) Sammensetning for behandling av smerte
BR9606066A (pt) Composto e formulação farmacêutica
AU1153997A (en) Biologically active compositions and their use
FR2736833B1 (fr) Composition super-absorbante et pansement contenant cette composition
FR2757360B1 (fr) Dispositif modulaire d'agencement, notamment du type gondole
BR9403411A (pt) Cadeira ativa
KR960033395U (ko) 의자의 구조
UA25337A (uk) Склад для передпосівhої обробки hасіhhя
KR940009243U (ko) 의자 등받이의 탄력기구